-+ 0.00%
-+ 0.00%
-+ 0.00%

QUOIN PHARMACEUTICALS: QRX003 IS ALSO CURRENTLY BEING EVALUATED IN LATE-STAGE CLINICAL TRIALS FOR NETHERTON SYNDROME

Reuters·10/14/2026 10:32:20